Chennai, Apr 23: Ranbaxy Laboratories Limited and Orchid Chemicals and Pharmaceuticals Limited have entered into a business alliance agreement involving multiple geographies and therapies for finished dosage formulations and active pharmaceutical ingredients.
Additionally, this agreement would establish a framework for enhanced future cooperation between the two companies, a release said here today. Ranbaxy CEO and MD Malvinder Mohan Singh said the agreement would be mutually beneficial and synergistic, allowing both the organisations to leverage each other's inherent strengths.
Commenting on the alliance, Orchid Chemicals MD K Raghavendra Rao said ''Ranbaxy's global scale and market reach and Orchid's state-of-the-art development and manufacturing capabilities would expand the business of both the companies. We believe that this will be a win-win arrangement for both the companies.''